Clinical Trial Update: The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients [NA]

View source ↗

Summary

A completed clinical trial assessed the impact of oral glutathione on oxidative damage and HbA1c levels in people with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• glutathione (oral) (glutathione)

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Type 2 Diabetes | NA | Status: COMPLETED